Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
The most recent EPS for Abbott Laboratories is $1.5, not beating expectations of $1.51.
How did Abbott Laboratories ABT's revenue perform in the last quarter?
Abbott Laboratories revenue for the last quarter is $1.5
What is the revenue estimate for Abbott Laboratories?
According to 26 of Wall street analyst, the revenue estimate of Abbott Laboratories range from $11.74B to $10.48B
What's the earning quality score for Abbott Laboratories?
Abbott Laboratories has a earning quality score of A-/61.57909. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Abbott Laboratories report earnings?
Abbott Laboratories next earnings report is expected in 2026-04-22
What are Abbott Laboratories's expected earnings?
Abbott Laboratories expected earnings is $11.92B, according to wall-street analysts.
Did Abbott Laboratories beat earnings expectations?
Abbott Laboratories recent earnings of $11.45B does not beat expectations.